Abstract
Transcatheter aortic valve replacement has recently established itself as the treatment of choice in inoperable and high-risk patients with aortic stenosis. Experience in this field has led to its usage for novel indications such as its use in the treatment of a degenerative biological surgical heart valves and is referred to as valve-in-valve (VIV). Early experience demonstrates that the procedure is not without risks. High residual gradients, coronary occlusion, embolization, and thrombosis have been reported. We aim to discuss relevant features of the different surgical and transcatheter devices and discuss the optimal strategy to avoid these complications after a VIV procedure.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S, PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.
Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ, PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98.
Reynolds MR, Magnuson EA, Wang K, Lei Y, Vilain K, Walczak J, Kodali SK, Lasala JM, O’Neil WW, Davidson CJ, Smith CR, Leon MB, Cohen DJ. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort B). Circulation. 2012;125:1102–9.
Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB, PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686–95.
Di Mario C, Eltchaninoff H, Moat N, Goicolea J, Ussia GP, Kala P, Wenaweser P, Zembala M, Nickenig G, Alegria Barrero E, Snow T, Iung B, Zamorano P, Schuler G, Corti R, Alfieri O, Prendergast B, Ludman P, Windecker S, Sabate M, Gilard M, Witowski A, Danenberg H, Schroeder E, Romeo F, Macaya C, Derumeaux G, Maggioni A, Tavazzi L, Transcatheter Valve Treatment Sentinel Registry (TCVT) Investigators of the EURObservational Research Programme (EORP) of the European Society of Cardiology. The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients. EuroIntervention. 2013;22(8):1362–71.
Eggebrecht H, Schäfer U, Treede H, Boekstegers P, Babin-Ebell J, Ferrari M, Möllmann H, Baumgartner H, Carrel T, Kahlert P, Lange P, Walther T, Erbel R, Mehta RH, Thielmann M. Valve-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves. JACC Cardiovasc Interv. 2011;4:1218–27.
Makkar RR, Jilaihawi H, Chakravarty T, Fontana GP, Kapadia S, Babaliaros V, Cheng W, Thourani VH, Bavaria J, Svensson L, Kodali S, Shiota T, Siegel R, Tuzcu EM, Xu K, Hahn RT, Herrmann HC, Reisman M, Whisenant B, Lim S, Beohar N, Mack M, Teirstein P, Rihal C, Douglas PS, Blackstone E, Pichard A, Webb JG, Leon MB. Determinants and outcomes of acute transcatheter valve-in-valve therapy or embolization: a study of multiple valve implants in the U.S. PARTNER trial (Placement of AoRTic TraNscathetER Valve Trial Edwards SAPIEN Transcatheter Heart Valve). J Am Coll Cardiol. 2013;62:418–30.
Ihlberg L, Nissen H, Nielsen NE, Rück A, Busund R, Klaarborg KE, Soendergaard L, Harnek J, Miettinen H, Eskola M, Wahba A, Laine M. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries. J Thorac Cardiovasc Surg. 2013;146:1047–54.
Dvir D, Webb J, Brecker S, Bleiziffer S, Hildick-Smith D, Colombo A, Descoutures F, Hengstenberg C, Moat NE, Bekeredjian R, Napodano M, Testa L, Lefevre T, Guetta V, Nissen H, Hernández JM, Roy D, Teles RC, Segev A, Dumonteil N, Fiorina C, Gotzmann M, Tchetche D, Abdel-Wahab M, De Marco F, Baumbach A, Laborde JC, Kornowski R. Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry. Circulation. 2012;126:2335–44.
Eggebrecht H, Schmermund A, Kahlert P, Erbel R, Voigtländer T, Mehta RH. Emergent cardiac surgery during transcatheter aortic valve implantation (TAVI): a weighted meta-analysis of 9,251 patients from 46 studies. EuroIntervention. 2013;8:1072–80.
Tay EL, Gurvitch R, Wijeysinghe N, Nietlispach F, Leipsic J, Wood DA, Yong G, Cheung A, Ye J, Lichtenstein SV, Carere R, Thompson C, Webb JG. Outcome of patients after transcatheter aortic valve embolization. JACC Cardiovasc Interv. 2011;4:228–34.
Cota L, Stabile E, Agrusta M, Sorropago G, Pucciarelli A, Ambrosini V, Mottola G, Esposito G, Rubino P. Bioprostheses “thrombosis” after transcatheter aortic valve replacement. J Am Coll Cardiol. 2013;61:789–91.
Mylotte D, Andalib A, Thériault-Lauzier P, Dorfmeister M, Girgis M, Alharbi W, Chetrit M, Galatas C, Mamane S, Sebag I, Buithieu J, Bilodeau L, de Varennes B, Lachapelle K, Lange R, Martucci G, Virmani R, Piazza N. Transcatheter heart valve failure: a systematic review. Eur Heart J. 2015;36(21):1306–27.
Taramasso M, Pozzoli A, Latib A, La Canna G, Colombo A, Maisano F, Alfieri O. New devices for TAVI: technologies and initial clinical experiences. Nat Rev Cardiol. 2014;11:157–67.
Kim WK, Kempfert J, Walther T, Möllmann H. Transfemoral valve-in-valve implantation of a St. Jude Medical Portico in a failing trifecta bioprosthesis: a case report. Clin Res Cardiol. 2015;104(4):363–5.
Van Linden A, Blumenstein J, Möllmann H, Kim WK, Walther T, Kempfert J. Image-based decision-making treatment of degenerated mitroflow and trifecta prostheses. Ann Thorac Surg. 2014;98:1809–13.
Kemfert J, Mollmann H, Walther T. Symetis ACURATE TA valve. Eurointervention. 2012;8(Suppl Q):Q102–9. doi:10.4244/EIJV8SQA19.
Piazza N, Bleiziffer S, Brockmann G, Hendrick R, Deutsch MA, Opitz A, Mazzitelli D, Tassani-Prell P, Schreiber C, Lange R. Transcatheter aortic valve implantation for failing surgical aortic bioprosthetic valve: from concept to clinical application and evaluation (part 2). J Am Coll Cardiol Cardiovasc Interv. 2011;4:733–42.
Pasic M, Unbehaun A, Dreysse S, Buz S, Drews T, Kukucka M, Hetzer R. Transapical aortic valve implantation after previous aortic valve replacement: clinical proof of the “valve-in-valve” concept. J Thorac Cardiovasc Surg. 2011;142:270–7.
Kempfert J, Van Linden A, Linke A, Borger MA, Rastan A, Mukherjee C, Ender J, Schuler G, Mohr FW, Walther T. Transapical off-pump valve-in-valve implantation in patients with degenerated aortic xenografts. Ann Thorac Surg. 2010;89:1934–41.
Khawaja MZ, Haworth P, Ghuran A, Lee L, de Belder A, Hutchinson N, Trivedi U, Laborde JC, Hildick-Smith D. Transcatheter aortic valve implantation for stenosed and regurgitant aortic valve bioprostheses CoreValve for failed bioprosthetic aortic valve replacements. J Am Coll Cardiol. 2010;55:97–101.
Bapat V, Mydin I, Chadalavada S, Tehrani H, Attia R, Thomas M. A guide to fluoroscopic identification and design of bioprosthetic valves: a reference for valve-in-valve procedure. Catheter Cardiovasc Interv. 2013;81:853–61.
Noorani A, Attia R, Bapat V. Valve-in-valve procedure: importance of the anatomy of surgical bioprostheses. Multimed Man Cardiothorac Surg. 2014. doi:10.1093/mmcts/mmu020.
Christakis GT, Buth KJ, Goldman BS, Fremes SE, Rao V, Cohen G. Inaccurate and misleading valve sizing: a proposed standard for valve size nomenclature. Ann Thorac Surg. 1998;66:1198–203.
Milburn K, Bapat V, Thomas M. Valve-in-valve implantations: is this the new standard for degenerated bioprostheses? Review of the literature. Clin Res Cardiol. 2014;103:417–29.
Bapat V, Davies W, Attia R, Hancock J, Bolter K, Young C, Redwood S, Thomas M. Use of balloon expandable transcatheter valves for valve-in-valve implantation in patients with degenerative stentless aortic bioprostheses: technical considerations and results. J Thorac Cardiovasc Surg. 2014;148:917–22.
Bapat V, Attia R, Redwood S, Hancock J, Wilson K, Young C, et al. Use of transcatheter heart valves for a valve-in-valve implantation in patients with degenerated aortic bioprosthesis: technical considerations and results. J Thorac Cardiovasc Surg. 2012;144:1372–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this chapter
Cite this chapter
Bapat, V.(., Attia, R., Aziz, W., Radia, R., Prione, F. (2016). Challenges in Valve-in-Valve Therapy for Aortic Valves. In: Ailawadi, G., Kron, I. (eds) Catheter Based Valve and Aortic Surgery. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3432-4_9
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3432-4_9
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-3430-0
Online ISBN: 978-1-4939-3432-4
eBook Packages: MedicineMedicine (R0)